2021
Long-QT founder variant T309I-Kv7.1 with dominant negative pattern may predispose delayed afterdepolarizations under β-adrenergic stimulation
SYNKOVÁ, Iva; Markéta BÉBAROVÁ; Irena ANDRŠOVÁ; Larisa CHMELIKOVA; Olga ŠVECOVÁ et. al.Základní údaje
Originální název
Long-QT founder variant T309I-Kv7.1 with dominant negative pattern may predispose delayed afterdepolarizations under β-adrenergic stimulation
Autoři
SYNKOVÁ, Iva; Markéta BÉBAROVÁ ORCID; Irena ANDRŠOVÁ; Larisa CHMELIKOVA; Olga ŠVECOVÁ ORCID; Jan HOSEK; Michal PÁSEK; Pavel VÍT; Iveta VALÁŠKOVÁ; Renata GAILLYOVÁ; Rostislav NAVRATIL a Tomáš NOVOTNÝ ORCID
Vydání
Nature Scientific Reports, London, NATURE RESEARCH, 2021, 2045-2322
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30101 Human genetics
Stát vydavatele
Německo
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.997
Kód RIV
RIV/00216224:14110/21:00120095
Organizační jednotka
Lékařská fakulta
UT WoS
000626725200007
EID Scopus
2-s2.0-85100735204
Klíčová slova anglicky
Long-QT founder variant T309I-Kv7.1; afterdepolarizations; β-adrenergic stimulation
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 5. 2022 08:52, Mgr. Tereza Miškechová
Anotace
V originále
The variant c.926C > T (p.T309I) in KCNQ1 gene was identified in 10 putatively unrelated Czech families with long QT syndrome (LQTS). Mutation carriers (24 heterozygous individuals) were more symptomatic compared to their non-affected relatives (17 individuals). The carriers showed a mild LQTS phenotype including a longer QTc interval at rest (466 ± 24 ms vs. 418 ± 20 ms) and after exercise (508 ± 32 ms vs. 417 ± 24 ms), 4 syncopes and 2 aborted cardiac arrests. The same haplotype associated with the c.926C > T variant was identified in all probands. Using the whole cell patch clamp technique and confocal microscopy, a complete loss of channel function was revealed in the homozygous setting, caused by an impaired channel trafficking. Dominant negativity with preserved reactivity to β-adrenergic stimulation was apparent in the heterozygous setting. In simulations on a human ventricular cell model, the dysfunction resulted in delayed afterdepolarizations (DADs) and premature action potentials under β-adrenergic stimulation that could be prevented by a slight inhibition of calcium current. We conclude that the KCNQ1 variant c.926C > T is the first identified LQTS-related founder mutation in Central Europe. The dominant negative channel dysfunction may lead to DADs under β-adrenergic stimulation. Inhibition of calcium current could be possible therapeutic strategy in LQTS1 patients refractory to β-blocker therapy.
Návaznosti
| NV16-30571A, projekt VaV |
|